Preprint Review Version 1 This version is not peer-reviewed

Assessment of Pharmacological Adherence Using Mobile Applications in Chronic Obstructive Pulmonary Disease: A Scoping Review

Version 1 : Received: 22 July 2024 / Approved: 23 July 2024 / Online: 24 July 2024 (12:27:01 CEST)

How to cite: Machado, B.; Quimbaya, P.; Bustos, R.-H.; Jaimes, D.; Cortes Palacio, K.; Vargas, D.; Perdomo, L. Assessment of Pharmacological Adherence Using Mobile Applications in Chronic Obstructive Pulmonary Disease: A Scoping Review. Preprints 2024, 2024071907. https://doi.org/10.20944/preprints202407.1907.v1 Machado, B.; Quimbaya, P.; Bustos, R.-H.; Jaimes, D.; Cortes Palacio, K.; Vargas, D.; Perdomo, L. Assessment of Pharmacological Adherence Using Mobile Applications in Chronic Obstructive Pulmonary Disease: A Scoping Review. Preprints 2024, 2024071907. https://doi.org/10.20944/preprints202407.1907.v1

Abstract

Chronic obstructive pulmonary disease (COPD) is a condition that significantly impacts both patients and healthcare systems. The management of COPD involves various pharmacological intervention strategies, and addressing the issue of low adherence to these strategies has become a subject of significant interest. In response to this concern, there has been a shift towards utilizing telemedicine and mobile applications. The primary objective of this scoping review is to delineate the usage of mobile applications to enhance pharmacological therapeutic adherence in adult patients with COPD. The study involved a search of databases such as Medline, Google Scholar, Cochrane, and ClinicalTrial.gov, focusing on literature published in English and Spanish over the last decade. The selected studies assessed interventions involving mobile applications (mobile apps) designed to improve pharmacological adherence. Four digital aids were identified, available on online platforms, mobile apps, or both: m-PAC, myCOPD, Wellinks mHealth, and Propeller Health. Pro-peller Health, in particular, is an app that directly measures pharmacological adherence through electronic medication monitors attached to participants' inhalers. Opening the app was associated with higher odds of using control medications compared to participants who did not open the app. The findings suggest that these digital interventions serve as valuable tools to enhance patient adherence to treatment. Future research should focus on evaluating the effectiveness of different digital devices, such as digital inhalers and mobile applications, that directly measure pharmacological adherence.

Keywords

medication adherence; pharmacological adherence; chronic obstructive pulmonary disease; mHealth; mobile applications.

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.